Herombopag Olamine Tablets (CXHS2000014-15) Application for Marketing Authorization Technical Review Report

Herombopag Olamine Tablets are a novel oral small molecule thrombopoietin receptor agonist indicated for the treatment of adult patients with severe aplastic anemia (SAA) who have had an inadequate response to immunosuppressive therapy (IST).

File format
PDF
Published
17 November, 2023
Updated
17 November, 2023
MD5 checksum
4EC88F92DC7B6DE61A0E0449C8211B85
PDF
Herombopag Olamine Tablets (CXHS2000014-15) Application for Marketing Authorization Technical Review Report PDF
Download PDF

Also Manuals

ManualLib.com

ManualLib.com is a comprehensive platform that offers an extensive collection of instruction manuals for a diverse range of products from around the globe. Our mission is to provide users with easy access to these manuals at all times and from any location, enabling them to make the most out of their purchases and improve their user experience.